1-3 of 3
Christian Bjorn Poulsen, MD.
Close
Sort by
Journal Articles

Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) - 15-Month Safety, Response and MRD Evaluation: Third Interim Analysis from the Phase II Vision HO141 Trial

Carsten Utoft Niemann, MD PhD, Julie Dubois, Sabina Kersting, MD PhD, Lisbeth Enggaard, MD, Gerrit J Veldhuis, Rogier Mous, MD PhD, Clemens Mellink, PhD, Johan A Dobber, Christian Bjørn Poulsen, MD, Henrik Frederiksen, MD Prof, Ann Janssens, Ida Schjødt, MD PhD, Ellen C Dompeling, Juha Ranti, Mattias Mattsson, MD, Mar Bellido, Hoa T Tran, Kazem Nasserinejad, Mark-David Levin, MD PhD, Arnon P. Kater, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4292.
https://doi.org/10.1182/blood-2019-124377
Published: 2019
Journal Articles

Risk of Death, Relapse or Progression, and Loss of Life Expectancy at Different Progression-Free Survival Milestones in Primary Central Nervous System Lymphoma

Jorne Lionel Biccler, MSc, BSc, Kerry J Savage, BSc, MD MSc, Peter de Nully Brown, MD PhD, Judit Jørgensen, MD PhD, Thomas Stauffer Larsen, MD PhD, Christian Bjørn Poulsen, MD, Danny Stoltenberg, MD, Lasse H. Jakobsen, Martin Bøgsted, Professor, Diego Villa, MD, Tarec C. El-Galaly
Journal: Blood
Blood (2018) 132 (Supplement 1): 1699.
https://doi.org/10.1182/blood-2018-99-114191
Published: 2018
Journal Articles

Different Subtypes of Difffuse Large B-Cell Lymphomas Identified Using Microarrays and Phenotyping.

Christian Bjorn Poulsen, MD., Rehannah Borup, Finn Cilius Nielsen, dr.med.sci, Niels Borregaard, dr.med. sci, Mads Hansen, dr.med.sci., Kirsten Gronbaek, MD, Elisabeth Ralfkiaer, dr.med.sci.
Journal: Blood
Blood (2004) 104 (11): 4293.
https://doi.org/10.1182/blood.V104.11.4293.4293
Published: 2004